G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2001
11/22/2001	WO2001088526A1 Biosensor and method for manufacturing the same
11/22/2001	WO2001088521A1 System and method for in-vivo hematocrit measurement using impedance and pressure plethysmography
11/22/2001	WO2001088517A2 Gas sensors with improved resistance to humidity interference
11/22/2001	WO2001088511A1 Grating optical waveguide structure for multi-analyte determinations and the use thereof
11/22/2001	WO2001088505A1 Photometric analysis of natural waters
11/22/2001	WO2001088501A1 Sample cylinder, especially a sample cylinder that is provided with a filtration device for recovering cell material from body fluids
11/22/2001	WO2001088500A1 Releasing embedding media from tissue specimens
11/22/2001	WO2001088257A1 Methods for analyzing boron-containing alkaline pulping liquors
11/22/2001	WO2001088199A2 Identification and modulationof of a t helper-1 and t helper-2 cells
11/22/2001	WO2001088197A2 Methods and compositions for interaction trap assays
11/22/2001	WO2001088196A2 Sequence based screening
11/22/2001	WO2001088193A2 Follicle stimulating hormone stimulated genes and uses thereof
11/22/2001	WO2001088190A2 Poly-primed amplification of nucleic acid sequences
11/22/2001	WO2001088188A2 Method for examining ischemic conditions
11/22/2001	WO2001088181A1 Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents
11/22/2001	WO2001088180A2 Tnf and ifn stimulated genes and uses therefor
11/22/2001	WO2001088177A2 Stain solution, which is devoid of phenol, for bacteria
11/22/2001	WO2001088162A2 Methods and vectors for generating antibodies in avian species and uses therefor
11/22/2001	WO2001088148A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/22/2001	WO2001088136A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	WO2001088131A1 Regulation of mt1-mmp activity
11/22/2001	WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	WO2001088126A2 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
11/22/2001	WO2001088116A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001088103A2 Compositions and methods for tissue dedifferentiation and regeneration
11/22/2001	WO2001088101A2 CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT
11/22/2001	WO2001088098A2 Fertilization of aged oocytes
11/22/2001	WO2001088089A2 Single copy genomic hybridization probes and method of generating same
11/22/2001	WO2001088087A2 Microfluidic channel embryo and/or oocyte handling, analysis and biological evaluation
11/22/2001	WO2001088042A1 Organic semi-conductive composition and sensor
11/22/2001	WO2001087983A1 Diagnostic method for screening complement regulatory protein levels to predict spontaneous abortion
11/22/2001	WO2001087981A2 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/22/2001	WO2001087980A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	WO2001087938A2 Polynucleotide sequence encoding a putative cell adhesion molecule
11/22/2001	WO2001087937A2 G-protein coupled receptors
11/22/2001	WO2001087935A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
11/22/2001	WO2001087923A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	WO2001087919A2 Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins
11/22/2001	WO2001087911A1 Method of identifying critical points within protein-protein interactions
11/22/2001	WO2001087833A2 System and method for managing and analyzing carbohydrate sequences
11/22/2001	WO2001087832A2 System and method for carbohydrate sequence presentation, comparison and analysis
11/22/2001	WO2001087567A1 Method and device for the dry separation of unsorted garbage that contains packaging waste
11/22/2001	WO2001087458A1 Magnetic bead-based arrays
11/22/2001	WO2001087352A1 Reverse isotope dilution assay and lactose intolerance assay
11/22/2001	WO2001087341A1 Agents for preventing or ameliorating insulin resistance and/or obesity
11/22/2001	WO2001087338A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	WO2001087335A2 Method for selectively inhibiting ghrelin action
11/22/2001	WO2001087302A1 Detection of antibodies to squalene in serum
11/22/2001	WO2001087300A1 Creatinine biosensor
11/22/2001	WO2001087059A1 Chimeric animal
11/22/2001	WO2001087057A1 Models of chronic and acute inflammatory diseases
11/22/2001	WO2001087055A2 New screening tool for analyzing the behavior of laboratory animals
11/22/2001	WO2001087039A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
11/22/2001	WO2001055333A8 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/22/2001	WO2001053826A8 Food contamination detection system for vacuum packaged food products
11/22/2001	WO2001036977A3 Identification of disease markers involving mass-based-separation
11/22/2001	WO2001036964A3 Device for testing samples of small volumes (1 to 100 microlitres)
11/22/2001	WO2001036639A3 Bt toxin receptors from lepidopteran insects and methods of use
11/22/2001	WO2001036476A3 Ing2, an iaps associated cell cycle protein, compositions and methods of use
11/22/2001	WO2001035995A3 Tr3-specific binding agents and methods for their use
11/22/2001	WO2001035072A3 A system for cell-based screening
11/22/2001	WO2001034642A3 Control of neisserial membrane synthesis
11/22/2001	WO2001031059A8 Genetic biosensors using chemiluminescence
11/22/2001	WO2001030969A8 Stanniocalcin proteins and nucleic acids and methods based thereon
11/22/2001	WO2001027146A3 Chemokine receptor
11/22/2001	WO2001020321A3 Conditioning and testing cotton fiber
11/22/2001	WO2001020042A3 Method for processing biological samples
11/22/2001	WO2001018548A3 Protecting alkylating reagents used for quantifying homocysteine
11/22/2001	WO2001018542A3 Identification, assessment, prevention, and therapy of ovarian cancer
11/22/2001	WO2001018169A3 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases
11/22/2001	WO2001016859A3 System and method for genomic and proteomic animal disease assessment via expression profile comparison
11/22/2001	WO2001016598A3 High throughput chemical profiling
11/22/2001	WO2001015655A3 Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders
11/22/2001	WO2001014564A3 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
11/22/2001	WO2001013109A3 Diapers containing chemical reagents for urine testing
11/22/2001	WO2001009611A3 An vivo identification of specific binding molecules for cancer detection
11/22/2001	WO2000056681A9 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
11/22/2001	WO2000055633A9 Methods of screening for colorectal cancer modulators
11/22/2001	US20010044699 Predicting metabolic stability of drug molecules
11/22/2001	US20010044584 In vivo delivery methods and compositions
11/22/2001	US20010044531 For probes, comprising a heterocycle condensed with a cyclic group such as ribofuranose derivative; biotin and 5-carboxyfluorescein derivatives
11/22/2001	US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
11/22/2001	US20010044522 Polypeptides, antibodies against them and nucleic acids encoding them; detecting activated CD4+ T-cells to diagnose a disease or condition of the immune system; screening for immunosuppressants
11/22/2001	US20010044414 Inhibiting metastasis in a mammal by administering an agent which alters the actin-based cytoskeleton of tumor cells; inhibiting specified genes involved in metastasis, RhoC for example; predicting likelihood of metastatic condition
11/22/2001	US20010044177 Manufacture of a microsensor device and a method for evaluating the function of a liquid by the use thereof
11/22/2001	US20010044159 A porous material comprising up to about 100% by weight silica; and up to about 60% alumina; wherein the material has a density about 6 pounds/cubic foot; useful for binding chemical and biological molecules
11/22/2001	US20010044158 Obtaining serum sample from patient, incubating Thomsen-Friedenreich (Tf)-like antigen sample, detecting autoantibody reactivity with Tf-like antigen in the sample, correlating an increased level of autoantibody to Tf-like
11/22/2001	US20010044157 Capillary printing systems
11/22/2001	US20010044154 Comprises mass transfer unit for gas conversion, gas equilibrium reservoir, oxygen removal unit, hydrogen sensor, and pump for moving carrier gas, all within fluid flow communication; for measuring hydrogen in aqueous solutions
11/22/2001	US20010044148 EBV-infected stomach cancer cell line
11/22/2001	US20010044144 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
11/22/2001	US20010044137 Sequence determination using polymerase chain reaction; Vaccinia virus linker
11/22/2001	US20010044134 Cytokines; transcription factors; for detection of cancer, genetic abnormalities
11/22/2001	US20010044127 Method for isotope labeling of protein with enzyme
11/22/2001	US20010044126 Predictive diagnostic for alzheimer's disease
11/22/2001	US20010044125 Determining the extent of agglutination of E. coli lipopolysaccharide on carrier particles by reacting an antilipopolysaccharide antibody with the sample.
11/22/2001	US20010044124 Method for determining the response to cancer therapy
11/22/2001	US20010044123 Detecting the capacity of a patient blood sample to inhibit the binding of annexin to a phospholipid substrate, blocking the anticoagulant activity of annexin
11/22/2001	US20010044122 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations

1 ... 2907 2908 2909 2910 2911 2912 2913 2914 2915 2916 2917 2918 2919 2920 2921 2922 2923 2924 2925 2926 2927 ... 3937